Development of Cancer Vaccine by Tumor Rejection Antigens

Reference

• Itoh K., Platsoucas CD., Balch CM. Autologous tumor specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. J. Exp. Med. 1988; 168: 1419–1441
   PubMed Web of Science ®Google Scholar
• Anichini A., Maccalli C, Mortarini R., Salvi S., Mazzocchi A., Squaricina P., Herlyn M., Parmiani G. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients. J. Exp. Med. 1993; 177: 989–998
   PubMedGoogle Scholar
• Van der Bruggen P., Traversari C, Chomez P., Lurquin C, De Plaen E., Van den Eynde B., Knuth A., Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on an human melanoma. Science 1991; 254: 1643–1647
   PubMed Web of Science ®Google Scholar
• Kawakami Y., Eliyahu S., Delgado C. H., Robbins P. F., Rivoltini L., Topalian S. L., Miki T., Rosenberg S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cell infiltrating into tumor. Proc. Natl. Acad. Sci. USA 1994; 91: 3515–3519
   PubMed Web of Science ®Google Scholar
• Coulie P. G., Brichard V., Van Pel A., Wölfel T., Schneider J., Boon T. A new gene coding for a differentiation antigen recognized by autologous cytologic T lymphocytes on HLA-A2 Traversari, C, Plaen, E.DE., Lurquin, C, Szikora, J.-P., Renauld, J.-C, melanomas. J. Exp. Med. 1994; 180: 35–42
   PubMed Web of Science ®Google Scholar
• Kawakami Y., Eliyahu S., Delgado C. H., Robbins P. F., Sakaguchi K., Appella E., Yannelli J. R., Adema G. J., Miki T., Rosenberg S. A. Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA 1994; 91: 6458–6462
   PubMed Web of Science ®Google Scholar
• Brichard V., Van Pel A., Wölfel T., Wölfel C, De Plaen E., Lethë B., Coulie P., Boon T. The tyrosinase gene codes for an antigen recognized autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 1993; 178: 489–495
   PubMed Web of Science ®Google Scholar
• De Plaen E., Arden K., Traversari C, Gaforio J. J., Szikora J.-P., De Smet C, Brasseur F., Van der Bruggen P., Lethë B., Lurquin C, Brassuer R., Chomez P., De Backer O., Cavenee W., Boon T. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994; 40: 360–369
   PubMed Web of Science ®Google Scholar
• Traversari C, Van der Bruggen P., Luescher I. F., Lurquin C, Chomez P., Van Pel A., De Plaen E., Amar-Costesec A., Boon T. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 1992; 176: 1453–1457
   PubMed Web of Science ®Google Scholar
• Van der Bruggen P., Szikora J.-P., Boel P., Wildmann C, Somville M., Sensi M., Boon T. Autologous cytotoxic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLACw 1601. Eur. J. Immunol. 1994; 24: 2134–2140
   PubMed Web of Science ®Google Scholar
• Van der Bruggen P., Bastin J., Gajewski T., Coulie P. G., Boel P., De Smet C, Traversari C, Townsend A., Boon T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytotoxic T lymohocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol. 1994; 24: 3038–3043
   PubMed Web of Science ®Google Scholar
• Gaugler B., Van den Eynde B., Van der Bruggen P., Romero P., Gaforio J. J., De Plaen E., Lethë B., Brasseur F., Boon T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 1994; 179: 921–930
   PubMed Web of Science ®Google Scholar
• De Smet C, Lurquin C, Van der Bruggen P., De Plaen E., Brasseur F., Boon T. Sequence and expression pattern of the human MAGE-2 gene. Immunogenetics 1994; 39: 121–129
   PubMedGoogle Scholar
• Weynants P., Lethë B., Brasseur F., Marchand M., Boon T. Expression of MAGE genes by non-small-cell lung carcinomas. Int. J. Cancer 1994; 56: 826–829
   PubMed Web of Science ®Google Scholar
• Zakut R., Topalian S. L., Kawakami Y., Mancini M., Eliyahu S., Rosenberg S. A. Differential expression of MAGE-1, -2 and -3 messenger RNA in transformed and normal human cell lines. Cancer Res. 1993; 53: 5–8
   PubMed Web of Science ®Google Scholar
• Brasseur F., Marchand M., Vanwijck R., Herin M., Lethë B., Chomez P., Boon T. Human gene MAGE-l, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int. J. Cancer 1992; 52: 839–841
   PubMed Web of Science ®Google Scholar
• Rimoldi D., Romero P., Carrel S. The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumour cells of neuroectodermal origin such as glioblastomas and neuroblastomas. Int. J. Cancer 1993; 54: 527–528
   PubMed Web of Science ®Google Scholar
• Shichijo S., Hayashi A., Takamori S., Tsunosue R., Hoshino T., Sakata M., Kuramoto T., Oizumi K., Itoh K. Detection of MAGE-4 protein on lung cancers. Int. J. Cancer 1995; 64: 158–165
   Google Scholar
• Toh Y., Yamana H., Shichijo S., Fujita H., Tou U., Sakaguchi M., Kakegawa T., Itoh K. Expression of MAGE-1 gene by esophageal carcinomas. Jap. J. Cancer Res. 1995, in press
   Google Scholar
• Shichijo S., Tsunosue R., Imai Y., Masuoka K., Natori H., Tamai M., Miyajima S., Sakata M., Sagawa K., Itoh K. Preferential expression of MAGE gene family on human lymphocytic leukemias. Cancer Immunol. Immunother. 1995, in press
   Google Scholar
• Eura M., Ogi K., Chikamatsu K., Dae L. K., Nakano K., Masuyama K., Itoh K., Ishikawa T. Expression of MAGE gene family by human head and neck squamous cell carcinomas. Int. J. Cancer 1995, in press
   Google Scholar
• Yamada A., Kataoka A., Shichijo S., Kamura T., Imai Y., Nishida T., Itoh K. Expression of MAGE genes in ovarian tumors. Int. J. Cancer 1995, in press
   Google Scholar
• Imai Y., Shichijo S., Yamada A., Katayama T., Yano H., Itoh K. Sequence analysis of the MAGE gene family encoding human tumor-rejection antigens. Gene 1995, in press
   Google Scholar
• Takahashi K., Shichijo S., Noguchi M., Hirohata M., Itoh K. Identification of MAGE-l and -4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res. 1995; vol. 55(no. 16), in press
   Google Scholar
• Chen Y-T., Stockert E., Chen Y., Garin-Chesa P., Rettig W. J., Van der Bruggen P., Boon T., Old L. J. Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies. Proc. Natl. Acad. Sci. USA 1994; 91: 1004–1008
   PubMed Web of Science ®Google Scholar
• Schultz-Thater E., Juretic A., Dellabona P., Luscher U., Siegrist W., Harder F., Heberer M.S., Zuber M., Spagnoli G. C. MAGE-l gene product is a Scytoplasmic protein. Int. J. Cancer 1994; 59: 435–439
   Google Scholar
• Russell L. D., Ettlin R. A., Shinha Hikim A. P., Clegg E. D. Mammalian Spermatogenesis. Histological and Histopathological Evaluation of the Testis, L. D. Russell, R. A. Ettlin, A. P. Shinha Hikim, E. D. Clegg, Clearwater, FI 1990; 1–40
   Google Scholar
• Becker J. C., Gillitzer R., Brocker E.-B. A member of the melanoma antigen-encoding gene (MAGE) family is expressed in human skin during wound healing. Int. J. Cancer 1994; 58: 346–348
   PubMedGoogle Scholar
• Shichijo S., Tsunosue R., Kubo K., Kuramoto T., Tanaka Y., Hayashi A., Itoh K. Establishment of an enzyme-linked immunosorbent assay (ELISA) for measuring cellular MAGE-4 protein on human cancers. J. Immunol. Melh. 1995, in press
   Google Scholar